Blood Center

Do you currently use the INTERCEPT™ Blood System, or are you considering implementing it in your blood centre? Learn more about the importance of blood safety, the risks involved in transfusion and the benefits of the INTERCEPT Blood System, including how it works and its affordability.

  • icon-bloodsafety2.png

    Blood safety

    The INTERCEPT™ Blood System has significantly enhanced blood safety at more than 100 blood centres worldwide. INTERCEPT offers proven pathogen inactivation of >5 logs for a broad range of enveloped and non-enveloped viruses, bacteria and protozoa, as well as leukocytes.
  • icon-economics2.png


    The INTERCEPT™ Blood System has been shown to offset costs through streamlined operations and provide significant clinical benefits via proactive reduction of transfusion-transmitted infections, at a minimal investment.
  • icon-intercept2.png


    The INTERCEPT™ Blood System is designed for high throughput processing of platelets and plasma from whole blood and apheresis collections.

Proven in Routine Use

Regulatory authorities concluded that INTERCEPT Platelets and Plasma are not clinically different from untreated products and may be prescribed and transfused in accordance with standard infusion methods.

The INTERCEPT Blood System is currently used to inactivate pathogens in platelets and plasma across Europe, CIS, the Middle East and USA.

The INTERCEPT™ Blood System is designed to reduce the risk of transfusion-transmitted diseases.